Klarskov, Carina Kirstine http://orcid.org/0000-0001-7702-8595
Lindegaard, Birgitte
Pedersen-Bjergaard, Ulrik
Kristensen, Peter Lommer
Funding for this research was provided by:
Novo Nordisk Fonden (NNF20SA0062872)
Grosserer LF Foghts Fond
Article History
Received: 2 November 2020
Accepted: 4 November 2020
First Online: 25 November 2020
Ethics approval and consent to participate
: The trial has been approved by The Regional Committee on Health Research Ethics for the Capital Region of Denmark on May 20. 2020 (reference number: H-20025305) and the Danish Data Protection Agency on March 25. 2020 (reference number P-2020-303).Before participating, all subjects are asked to sign a consent form after receiving oral and written information about the study. We certify that this trial has received ethical approval from the appropriate ethical committee as described above.
: Not applicable.
: BL has received lecture fees from Astra Zeneca.PLK has received lecture fees from Astra Zeneca.UP-B has served on advisory boards for AstraZeneca, Bristol-Myers Squibb, Sanofi-Aventis, Novo Nordisk, and Zealand Pharma and has received lecture fees from AstraZeneca, Bristol-Myers Squibb, Sanofi-Aventis and Novo Nordisk.CKK None.